ImmunoSep
Personalized immunotherapy in sepsis: a precision medicine based approach
- Description
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, and is characterized by a high mortality of up to 30-40%. The mission of the present project is to design and perform a proof-of-concept clinical trial of personalized immunotherapy in sepsis, and within this clinical trial, to develop a next-generation theranostics platform for the design of future personalized immunotherapy trials in sepsis.
- Coordinator
- Programme
- Horizon 2020 & sub-programmes
- Duration
- 54 months (January 2020 - June 2024)
- Project funding
- € 10,081,333.75
- Project partners
- 14